Kruithof PD, Brouns AJWM, Degens JHRJ, Hendriks LEL, et al. Osimertinib Dose Optimization Guided by Therapeutic Drug Monitoring in Patients With EGFR-Mutated Advanced Non-Small Cell Lung Cancer: A Case series. Clin Lung Cancer 2025 May 29:S1525-7304(25)00125.
PMID: 40537319